Balaji Amines (NSE:BALAMINES) Marketable Securities: ₹1,959 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BALAMINES Balaji Amines Ltd NSE:BALAMINES
78 GF Score
Price ₹2,289.10
GF Value ₹1,665.83
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Balaji Amines Marketable Securities?

Balaji Amines NSE:BALAMINES -3.49% 78 Marketable Securities is ₹1,959 Mil as of Mar. 2026. GuruFocus rates NSE:BALAMINES with a GF Score™ of 78/100 and a GF Value™ of ₹1,665.83 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Balaji Amines's Marketable Securities for the quarter that ended in Mar. 2026 was ₹1,959 Mil.

Balaji Amines's annual Marketable Securities declined from Mar. 2024 (₹2,494 Mil) to Mar. 2025 (₹2,014 Mil) and declined from Mar. 2025 (₹2,014 Mil) to Mar. 2026 (₹1,959 Mil).

Balaji Amines  (NSE:BALAMINES) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Balaji Amines Marketable Securities Related Terms

Balaji Amines Marketable Securities Historical Data

* Premium members only.

The historical data trend for Balaji Amines's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Balaji Amines Marketable Securities Chart

Balaji Amines Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 184.11 2,121.50 2,494.15 2,013.53 1,958.61

Balaji Amines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,013.53 0.00 1,470.83 0.00 1,958.61
NSE:BALAMINES
78GF Score
Balaji Amines Ltd NSE:BALAMINES
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Balaji Amines Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹1,959 Mil mean?
Balaji Amines (NSE:BALAMINES) has a Marketable Securities of ₹1,959 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Balaji Amines and its competitors.
Is Balaji Amines' Marketable Securities too high?
Balaji Amines' current Marketable Securities is ₹1,959 Mil. Overall, Balaji Amines has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Balaji Amines' Marketable Securities compare to LIN and SHW?
Balaji Amines' Marketable Securities of ₹1,959 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Chemicals company?
A good Marketable Securities depends on the Chemicals industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Balaji Amines and its competitors. Balaji Amines's current Marketable Securities is ₹1,959 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balaji Amines stock overvalued right now?
Based on GuruFocus' analysis, Balaji Amines (NSE:BALAMINES) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,665.83, compared to a current price of ₹2,289.10 — trading 37.4% above its estimated fair value. The current Marketable Securities is ₹1,959 Mil. Balaji Amines' overall GF Score™ is 78/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Balaji Amines (NSE:BALAMINES), the current Marketable Securities is ₹1,959 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Balaji Amines (NSE:BALAMINES) Overvalued in 2026?

Based on GuruFocus' analysis, Balaji Amines stock appears to be overvalued. The current stock price of ₹2,289.10 is trading 37.4% above its estimated GF Value™ of ₹1,665.83. GuruFocus considers Balaji Amines to be Significantly Overvalued.

Key valuation signals for NSE:BALAMINES:

  • Marketable Securities: ₹1,959 Mil
  • GF Value™: ₹1,665.83 vs. price of ₹2,289.10 (37.4% above fair value)
  • GF Score™: 78/100 with 9 warning signs

No single metric tells the full story. See the NSE:BALAMINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Balaji Amines Business Description

Other Exchanges 530999:India
Address Plot No. 47, Kavuri Hills, Balaji Bhawan, Behind Jubilee Ridge Hotel, Madhapur, Hyderabad, TG, IND, 500 003
Balaji Amines Ltd is engaged in the manufacture and sale of aliphatic amines, speciality chemicals, and their derivatives. The Company's manufacturing facilities operate through Distributed Control Systems (DCS), indigenous process technologies, and a Zero Liquid Discharge (ZLD) framework. The business operates through the Chemicals and Hotel segments, with the Chemicals segment generating maximum revenue. Its products include amines such as Mono Methyl Amine (MMA), Di-Methyl Amine (DMA) and others; speciality chemicals such as Morpholine, Acetonitrile (ACN), and others; and amine derivatives such as Mono-Methyl Amine Hydrochloride (MMA HCL), Di-Methyl Amine Hydrochloride (DMA HCL) and others. Geographically, the Company generates maximum revenue from India.
78GF Score

Get the complete analysis for NSE:BALAMINES

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,289.10
Price
₹1,665.83
GF Value